Drug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 3.9% from $6.09 billion last year to $5.85 billion.
Pharmacy sales in November fell 4.7%, and same-store pharmacy sales fell 8.8%. Pharmacy sales accounted for 63.2% of monthly sales.
Walgreen did not specifically indicate any impact from its now-resolved dispute with Express Scripts Inc. (NASDAQ: ESRX). During the nine-month fight with Express Scripts, Walgreen’s lost millions of customers, and as much as 60% of the total could be gone permanently to competitor CVS Caremark Corp. (NYSE: CVS). Walgreen did say that prescriptions filled at comparable stores fell by 2.9% in November following a 1.8% drop in October.
Walgreen stock is up 2.45% this morning, at $35.12 in a 52-week range of $28.53 to $37.35, even though virtually every metric reported today was down. Even the number of flu shots administered is lower this year.
Paul Ausick
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.